Le Lézard
Classified in: Science and technology, Business

Frank Hwang Joins Senné as Chief Marketing Officer


BOSTON, Aug. 13, 2020 /PRNewswire-PRWeb/ -- Senné is pleased to announce the hiring of Frank Hwang as Chief Marketing Officer. As CMO, Frank will lead Senné's creative team and manage marketing and brand strategy across the entire company. Frank will work directly with the CEO and Marketing Director to expand the company's reach and continue to develop the innovative ideas that place Senné at the forefront of the real estate industry.

"I'm thrilled and honored to join Senné at this pivotal time in the company's history," said Frank. "Alongside our team of experts, I look forward to bringing our creative ideas to life and showcasing the amazing work being done here."

Frank is a digital-first global marketer who joins Senné with over 16 years of experience across multiple consumer industries. He specializes in building or revitalizing brands to achieve key business objectives. Frank is a true leader who loves to work with high-energy teams to tackle new challenges and develop original tactics that improve any client or consumer experience.

Prior to Senné, Frank was the Vice President of Marketing and Communications for EF Pro Cycling, where he developed and executed the overall marketing strategy of the company's professional sports product, driving broader consumer interest and generating new sales leads. Frank was also the Senior Director of Digital Marketing and Public Relations for Sperry and Senior Manager for Digital Marketing, Advertising, and Media at Timberland. At Sperry and Timberland, he spearheaded the development of consumer insight-led strategies and campaigns to create growth at the forefront of marketing. Frank's experience in invigorating and revitalizing global brands will help take Senné to new heights.

"Our investment in creative and innovative marketing is a testament to our commitment and support of our clients with what's needed in the marketplace. This is one of many things that sets Senné apart from other real estate firms," said William Senné, President and CEO. "Frank is an incredible leader with a clear ability to help us articulate and execute the next chapter of our brand's vision. As CMO, Frank will elevate and innovate our marketing to better serve our existing clients and attract future clients. Our industry is changing rapidly, and our agile team is prepared to adapt and respond to new challenges and opportunities."

Senné is an industry-leading real estate advisory and investment firm headquartered in Boston, Massachusetts. Senné is privately held and comprised of specialists in brokerage, valuation, management, finance, marketing, construction, design, and urban planning. Using the full power of a diverse team of experts, Senné builds innovative solutions for a broad mix of local, regional, and international clients to help them achieve their most important goals.

Media contact:
Debora Almeida
Tel: 617.934.8220
Email: [email protected]

 

SOURCE Senné


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: